A carregar...
Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality and health care expenditure throughout the world. COPD guidelines recommend the use of long-acting muscarinic antagonist (LAMA) either alone or in combination with a long-acting β(2) agonist (LABA). For over 10 y...
Na minha lista:
| Publicado no: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406010/ https://ncbi.nlm.nih.gov/pubmed/28491268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622317700822 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|